Comparison of Treatment Modalities in Poor Responders Undergoing IVF

Status Completed

Clinical Trial Summary

The accurate identification and efficient management of poor responders remains one of the most enigmatic challenges in assisted reproductive technology (ART). The investigators study will compare the letrozole/antagonist protocol to the hMG/antagonist protocol in women who poor responders.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Poor Responders

Clinical Trial Details

NCT number	NCT02158689
Study type	Interventional
Source	Istanbul University
Contact
Status	Completed
Phase	N/A
Start date	June 2014
Completion date	August 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03438812` - Dehydroepiandrosterone Maintain Mitochondrial Quality of Cumulus Cells in Poor Ovarian Responders	N/A
Not yet recruiting	`NCT05900661` - The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders	Phase 2/Phase 3
Recruiting	`NCT04487925` - Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders	Phase 4
Recruiting	`NCT02201914` - Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF	Phase 4